Holen Sie sich die Stockscreener-App
5.47
0.72%
-0.05
Schlusskurs vom Vortag:
$5.52
Offen:
$5.55
24-Stunden-Volumen:
708.75K
Relative Volume:
0.59
Marktkapitalisierung:
$699.42M
Einnahmen:
$193.01M
Nettoeinkommen (Verlust:
$-12.15M
KGV:
-60.78
EPS:
-0.09
Netto-Cashflow:
$454.00K
1W Leistung:
+8.51%
1M Leistung:
+9.82%
6M Leistung:
+61.18%
1J Leistung:
-20.46%
1-Tages-Spanne:
$5.46
$5.61
1-Wochen-Bereich:
$4.895
$5.61
52-Wochen-Spanne:
$2.37
$7.30
Cytek Biosciences Inc Stock (CTKB) Company Profile
Firmenname
Cytek Biosciences Inc
Sektor
Branche
Telefon
(877) 922-9835
Adresse
47215 LAKEVIEW BOULEVARD, FREMONT
Vergleichen Sie CTKB mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CTKB
Cytek Biosciences Inc
|
5.47 | 705.81M | 193.01M | -12.15M | 454.00K | -0.09 |
|
ABT
Abbott Laboratories
|
126.98 | 222.19B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
98.60 | 144.97B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
367.11 | 140.12B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
99.45 | 128.60B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
84.56 | 49.82B | 5.88B | 1.34B | 799.60M | 2.3489 |
Cytek Biosciences Inc Stock (CTKB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-02 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2025-05-09 | Herabstufung | TD Cowen | Buy → Hold |
| 2025-01-31 | Herabstufung | Goldman | Buy → Sell |
| 2023-12-14 | Eingeleitet | Stephens | Overweight |
| 2023-07-19 | Eingeleitet | Raymond James | Mkt Perform |
| 2022-01-06 | Fortgesetzt | Piper Sandler | Overweight |
Alle ansehen
Cytek Biosciences Inc Aktie (CTKB) Neueste Nachrichten
Is Cytek Biosciences (NASDAQ:CTKB) Using Debt In A Risky Way? - 富途牛牛
2026 world cup standings odds: How currency fluctuations impact Cytek Biosciences Inc. stock2026 world cup usa national team round of 16 playmakers transition play match prediction analysis - ulpravda.ru
Cytek Biosciences Inc 8EQ Stock Analysis and ForecastCandlestick Pattern Analysis & Affordable Portfolio Strategies - earlytimes.in
What risks investors should watch in Cytek Biosciences Inc stockGap Down & Free Safe Capital Growth Stock Tips - moha.gov.vn
How currency fluctuations impact Cytek Biosciences Inc. stockStock Screening Results & Big Data Market Reports - bollywoodhelpline.com
Why Cytek Biosciences Inc. (8EQ) stock attracts HNW investorsTrading Psychology Tips & Small Entry Cost Trading - bollywoodhelpline.com
What dividend safety score for Cytek Biosciences Inc. stockLong-Term Investment Plans & Fast Profit Trading Strategies - bollywoodhelpline.com
Cytek Biosciences webinar explores lung cell communication advances - Traders Union
Cytek Biosciences Data Breach Investigation - Claim Depot
Cytek Biosciences Data Breach Exposes Social Security Numbers - Claim Depot
Book value per share of Cytek Biosciences, Inc. – DUS:8EQ - TradingView — Track All Markets
How Cytek Biosciences Inc. stock responds to policy changes2025 Trading Volume Trends & Accurate Buy Signal Alerts - Улправда
Pharma News: How Cytek Biosciences Inc. stock responds to policy changesJuly 2025 Sector Moves & Expert-Curated Trade Recommendations - Улправда
Is Cytek Biosciences Inc. (8EQ) stock a buy on weakness2025 EndofYear Setup & Safe Capital Preservation Plans - DonanımHaber
Is Cytek Biosciences Inc. (8EQ) stock at risk of policy regulationTrade Ideas & High Accuracy Trade Signal Alerts - DonanımHaber
Cytek Biosciences Earnings Notes - Trefis
Cytek Biosciences, Inc. (NASDAQ:CTKB) Given Consensus Recommendation of "Hold" by Brokerages - MarketBeat
Cytek BioSciences Inc (CTKB) expanding its growth trajectory ahead - Setenews
Why Cytek Biosciences Inc. (8EQ) stock stays on buy listsQuarterly Portfolio Report & High Accuracy Buy Signal Tips - Newser
Institutional Owners May Consider Drastic Measures as Cytek Biosciences, Inc.'s (NASDAQ:CTKB) Recent US$58m Drop Adds to Long-term Losses - 富途牛牛
Brown Capital Management LLC Has $24.17 Million Stock Position in Cytek Biosciences, Inc. $CTKB - MarketBeat
Is Cytek Biosciences Inc. stock overvalued by current metricsJuly 2025 EndofMonth & Precise Entry and Exit Recommendations - Newser
Can Cytek Biosciences Inc. stock beat market expectations this quarter - Newser
Can Cytek Biosciences Inc. (8EQ) stock sustain revenue momentumGDP Growth & Safe Capital Growth Plans - Newser
Why Cytek Biosciences Inc. stock attracts global investorsWeekly Trend Report & Fast Gain Stock Tips - Newser
Can Cytek Biosciences Inc. stock maintain operating marginsEarnings Growth Summary & Entry Point Strategy Guides - Newser
Is Cytek Biosciences Inc. (8EQ) stock attractive for dividend growthJuly 2025 Sentiment & Community Verified Trade Alerts - Newser
What is Cytek BioSciences Inc (CTKB) Stock Return on Shareholders’ Capital? - setenews.com
Tranche Update on Cytek Biosciences, Inc.'s Equity Buyback Plan announced on December 30, 2024. - marketscreener.com
Will Cytek Biosciences Inc. (8EQ) stock draw ESG focused funds2025 Fundamental Recap & AI Driven Stock Price Forecasts - Newser
Morgan Stanley Raises Price Target on Cytek Biosciences to $6 From $4, Keeps Equalweight Rating - marketscreener.com
Cytek Biosciences (CTKB) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Published on: 2025-12-02 04:27:45 - Newser
Check out these key findings about Cytek BioSciences Inc (CTKB) - Setenews
Cytek Biosciences, Inc. (NASDAQ:CTKB) Receives Average Rating of "Hold" from Brokerages - MarketBeat
Bank of Montreal Can Boosts Stock Position in Cytek Biosciences, Inc. $CTKB - Defense World
Revenues Tell The Story For Cytek Biosciences, Inc. (NASDAQ:CTKB) As Its Stock Soars 43% - simplywall.st
[Form 4] Cytek Biosciences, Inc. Insider Trading Activity - Stock Titan
Officer/Dir Yan Acquires 15,908 Of Cytek BioSciences Inc [CTKB] - TradingView
Finanzdaten der Cytek Biosciences Inc-Aktie (CTKB)
Umsatz
Nettogewinn
Free Cashflow
ENV
Cytek Biosciences Inc-Aktie (CTKB) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| McCombe William D. | Chief Financial Officer |
Jun 02 '25 |
Buy |
2.78 |
35,000 |
97,300 |
55,746 |
1.20%
0.48%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):